116 related articles for article (PubMed ID: 2958711)
1. Characterization of murine interleukin B by a monoclonal antibody.
del Guercio P; del Guercio MF; Katz DH
Nature; 1987 Oct 1-7; 329(6138):445-7. PubMed ID: 2958711
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
Matsuda T; Hirano T; Kishimoto T
Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
[TBL] [Abstract][Full Text] [Related]
3. B lymphocyte regulation of the immune system. I. In vivo biologic activity of the novel lymphokine, B cell-derived enhancing factor (BEF).
del Guercio P; del Guercio MF; Katz DH
J Immunol; 1985 Feb; 134(2):996-1002. PubMed ID: 3871223
[TBL] [Abstract][Full Text] [Related]
4. T-cell-derived factor B151-TRF1/IL-5 activates blastoid cells among unprimed B cells to induce a polyclonal differentiation into immunoglobulin M-secreting cells.
Murakami S; Ono S; Harada N; Hara Y; Katoh Y; Dobashi K; Takatsu K; Hamaoka T
Immunology; 1988 Oct; 65(2):221-8. PubMed ID: 3263941
[TBL] [Abstract][Full Text] [Related]
5. B lymphocyte regulation of the immune system. II. Inhibition of Fc receptor expression of lymphocytes by BEF, a lymphokine of B cell origin.
del Guercio P; Zanetti M; del Guercio MF; Katz DH
J Immunol; 1985 Jun; 134(6):3926-33. PubMed ID: 3157754
[TBL] [Abstract][Full Text] [Related]
6. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
[TBL] [Abstract][Full Text] [Related]
7. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
8. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
10. Regulation of rat B cell responses by T cell subsets and interleukin 2.
Rosenberg JS; Gilman SC; Feldman JD
J Immunol; 1982 Sep; 129(3):996-1001. PubMed ID: 6809819
[TBL] [Abstract][Full Text] [Related]
11. The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin.
Hoffmann MK
J Immunol; 1988 Jan; 140(2):580-2. PubMed ID: 2826594
[TBL] [Abstract][Full Text] [Related]
12. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
Osawa H; Diamantstein T
J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cell regulation of B-lymphopoiesis. I. The role of macrophages, IL-1, and IL-4 in pre-B cell maturation.
King AG; Wierda D; Landreth KS
J Immunol; 1988 Sep; 141(6):2016-26. PubMed ID: 3262646
[TBL] [Abstract][Full Text] [Related]
14. Regulatory function of Thy-1-negative cells: V. A lymphokine of B cell origin (BEF) induces in vitro high antibody response in genetically selected low responder mice.
del Guercio P; Mouton D; del Guercio MF; Biozzi G
J Immunogenet; 1985 Feb; 12(1):45-53. PubMed ID: 2931487
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s).
Wardzala AM; Bowen MB; Jendrisak GS; Bellone CJ
J Mol Cell Immunol; 1986; 2(5):243-53. PubMed ID: 2978231
[TBL] [Abstract][Full Text] [Related]
16. Increased autoantibody production by NZB/NZW B cells in response to IL-5.
Herron LR; Coffman RL; Bond MW; Kotzin BL
J Immunol; 1988 Aug; 141(3):842-8. PubMed ID: 2969393
[TBL] [Abstract][Full Text] [Related]
17. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
18. Recombinant T cell replacing factor (interleukin 5) acts with antigen to promote the growth and differentiation of single hapten-specific B lymphocytes.
Alderson MR; Pike BL; Harada N; Tominaga A; Takatsu K; Nossal GJ
J Immunol; 1987 Oct; 139(8):2656-60. PubMed ID: 3498766
[TBL] [Abstract][Full Text] [Related]
19. Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line.
Landreth KS; Dorshkind K
J Immunol; 1988 Feb; 140(3):845-52. PubMed ID: 3276783
[TBL] [Abstract][Full Text] [Related]
20. Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.
Stein P; Dubois P; Greenblatt D; Howard M
J Immunol; 1986 Mar; 136(6):2080-9. PubMed ID: 3081637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
